<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03997253</url>
  </required_header>
  <id_info>
    <org_study_id>87RI18-0027</org_study_id>
    <nct_id>NCT03997253</nct_id>
  </id_info>
  <brief_title>Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management</brief_title>
  <acronym>BIOSUPORT</acronym>
  <official_title>Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Increased indications for transplantation continue to worsen the shortage of organs and need&#xD;
      the extension of graft sampling criteria and the search for new potential sources of organs.&#xD;
      Despite undeniable success in the short term, due to major advances in surgery, medicine and&#xD;
      research, transplant recipients continue to face the risk of chronic rejection and long-term&#xD;
      complications.&#xD;
&#xD;
      The University Hospital Federation (UHF) &quot;SUPORT&quot; was created to optimize the chances of&#xD;
      success of the organ transplant and improve the quality of life of the transplanted patient.&#xD;
      UHF SUPORT 's ambition is based on a translational strategy that presents two priority areas:&#xD;
&#xD;
      Axis 1: Optimization, evaluation, conditioning of the donor, graft, recipient Axis 2:&#xD;
      Personalized follow-up of the transplanted patient in the short and long term Identifying&#xD;
      factors for long-term graft and patient survival through translational research from a common&#xD;
      cohort and biological collection will predict transplant rejection, prolong graft function,&#xD;
      or improve the patient's care.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2020</start_date>
  <completion_date type="Anticipated">November 2024</completion_date>
  <primary_completion_date type="Anticipated">February 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>various blood and urine samples will be collected from the recipient at D0, D7, D14, M1, M3, M6 and M12</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival of the graft</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Organ Transplantation</condition>
  <arm_group>
    <arm_group_label>blood and urine samples</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>blood and urine samples at D0, D7, D14, M1, M3, M6 and M12</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood and urine samples</intervention_name>
    <description>various blood and urine samples will be collected from the recipient at D0, D7, D14, M1, M3, M6 and M12.</description>
    <arm_group_label>blood and urine samples</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female over 18 (no age limit)&#xD;
&#xD;
          -  affiliated to a social security organization&#xD;
&#xD;
          -  Recipient (s) of a kidney, liver or heart transplant&#xD;
&#xD;
          -  followed by at least one of the UHF SUPORT centers (Tours, Poitiers, Limoges)&#xD;
&#xD;
          -  having given informed consent to participate in the cohort.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient unable to understand the information given by the investigator&#xD;
&#xD;
          -  People under the protection of justice&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sophie ALAIN, MD</last_name>
    <phone>+33 5 55 056 728</phone>
    <email>sophie.alain@unilim.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Limoges hospital</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Alain, MD</last_name>
      <phone>+33 5 55 056 728</phone>
      <email>sophie.alain@unilim.fr</email>
    </contact>
    <investigator>
      <last_name>VÃ©ronique Loustaud-Ratti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Philippe Rerolle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Poitiers Hospital</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Thierry, MD</last_name>
      <email>a.thierry@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Antoine Thierry</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christine Silvain</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tours hospital</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ephrem Salame, MD</last_name>
      <email>ephrem.salame@univ-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Ephrem Salame</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Buchler</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>June 24, 2019</study_first_submitted>
  <study_first_submitted_qc>June 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2019</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>organ transplantation, graft, biological collection.</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

